• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Semble

To add a bio or update company history, please click update information.

News from Semble

    Semble secures £30m Series C led by Revaia to expand its healthcare coordination platform for outpatient providersSemble secures £30m Series C led by Revaia to expand its healthcare coordination platform for outpatient providers
    Semble
    4 Jun 2026

    Semble secures £30m Series C led by Revaia to expand its healthcare coordination platform for outpatient providers

    Semble is a healthcare management platform for outpatient providers that connects and coordinates every stage of the patient journey. The platform integrates with over 1,200 external tools across diagnostics, billing, labs and CRM, serving solo clinicians, group practices and enterprise healthcare organisations.

    Semble closes £11.5m Series B round for "connected healthcare" systemSemble closes £11.5m Series B round for "connected healthcare" system
    Semble
    29 Oct 2024

    Semble closes £11.5m Series B round for "connected healthcare" system

    Semble provides an integrated clinical system that automates healthcare administration and connects with third-party services, helping providers reduce paperwork and focus more on patient care.

Semble
  • Health
  • London, United Kingdom
  • £30m
  • semble.io
  • Update Information

More venture news

  • Mirae lands £4m in funding from Oxford Science Enterprises for conversational AI platform that tracks autoimmune disease between clinic visits
    Mirae
    29 Jul 2026

    Mirae lands £4m in funding from Oxford Science Enterprises for conversational AI platform that tracks autoimmune disease between clinic visits

    EquityHealth
  • DITTO lands a £4.5m seed round led by FoodLabs to develop evidence-based menstrual health supplements
    DITTO
    28 Jul 2026

    DITTO lands a £4.5m seed round led by FoodLabs to develop evidence-based menstrual health supplements

    SeedHealth
  • TidalSense secures £14m in funding from VCs to roll out AI-driven breath test for lung disease
    TidalSense
    24 Jul 2026

    TidalSense secures £14m in funding from VCs to roll out AI-driven breath test for lung disease

    EquityHealth

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn